[The impact and mechanism of hypoglycemic drugs on the development and progression of sarcopenia].

Shi, P J; Li, Y B; Xiao, H P

Shi, P J; Li, Y B; Xiao, H P.

Affiliation

Shi PJ; Department of Endocrinology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Li YB; Department of Endocrinology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Xiao HP; Department of Endocrinology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.

Zhonghua Nei Ke Za Zhi ; 63(8): 809-815, 2024 Aug 01.

Article in Zh | MEDLINE | ID: mdl-39069873

Subject(s)

Hypoglycemic Agents; Sarcopenia; Humans; Sarcopenia/chemically induced; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcopenia / Hypoglycemic Agents Limits: Humans Language: Zh Journal: Chung-Hua Nei Ko Tsa Chih (Chinese Journal of Internal Medicine) / Zhonghua Nei Ke Za Zhi Year: 2024 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google